[PDF][PDF] B ritish HIV Association guidelines for HIV‐associated malignancies 2014

Writing Group, M Bower, A Palfreeman, M Alfa‐Wali… - HIV medicine, 2014 - academia.edu
British HIV Association guidelines for HIV‐associated malignancies 2014 Page 1 DOI:
10.1111/hiv.12136 © 2014 British HIV Association HIV Medicine (2014), 15 (Suppl. 2), 1Ȃ92 …

Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada

K Robertson, C Bayon, JM Molina, P McNamara… - AIDS care, 2014 - Taylor & Francis
CRANIum, a cross-sectional epidemiology study in Western Europe and Canada, was
conducted to describe and compare the prevalence of a positive screen for neurocognitive …

Mapping the brain in younger and older asymptomatic HIV-1 men: frontal volume changes in the absence of other cortical or diffusion tensor abnormalities

KJ Towgood, M Pitkanen, R Kulasegaram, A Fradera… - Cortex, 2012 - Elsevier
INTRODUCTION: Over the past decade the developments made in treating people with
human immune deficiency virus (HIV) have greatly improved quality of life and life …

Regional cerebral blood flow and FDG uptake in asymptomatic HIV‐1 men

KJ Towgood, M Pitkanen, R Kulasegaram… - Human brain …, 2013 - Wiley Online Library
Despite advances in the treatment of patients with human immunodeficiency virus (HIV), HIV‐
associated neurocognitive disorder occurs in 15–50% of HIV‐infected individuals, and may …

[PDF][PDF] British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013

E Wilkins, M Nelson, K Agarwal, D Awoyemi, E Barnes… - HIV medicine, 2013 - rushiv.ru
British HIV Association guidelines for the management of hepatitis viruses in adults infected
with HIV 2013 Page 1 DOI: 10.1111/hiv.12106 © 2013 British HIV Association HIV Medicine …

HIV lipodystrophy and its metabolic consequences: implications for clinical practice

AS Wierzbicki, SD Purdon, TC Hardman… - Current Medical …, 2008 - Taylor & Francis
Background: The introduction of highly active antiretroviral therapy (HAART) around 1996
markedly reduced mortality and morbidity from human immunodeficiency virus (HIV) …

Short‐duration pan‐genotypic therapy with Glecaprevir/Pibrentasvir for 6 weeks among people with recent hepatitis C viral infection

M Martinello, C Orkin, G Cooke, S Bhagani… - …, 2020 - Wiley Online Library
Background and Aims Among treatment‐naive individuals with chronic hepatitis C viral
(HCV) infection and without cirrhosis, glecaprevir/pibrentasvir for 8 weeks is recommended …

Clinical outcomes of patients with and without HIV hospitalized with COVID‐19 in England during the early stages of the pandemic: a matched retrospective multi …

MJ Lee, LB Snell, ST Douthwaite, S Fidler… - HIV …, 2022 - Wiley Online Library
Background The contribution of HIV to COVID‐19 outcomes in hospitalized inpatients
remains unclear. We conducted a multi‐centre, retrospective matched cohort study of SARS …

Dyslipidaemia and cardiovascular risk in HIV infection

R Kulasegaram, BS Peters… - Current medical research …, 2005 - Taylor & Francis
Cardiovascular disease is increasingly recognised as a consequence of human
immunodeficiency virus (HIV) infection in the era of highly active anti-retroviral therapy …

VirA+ EmiC project: Evaluating real‐world effectiveness and sustainability of integrated routine opportunistic hepatitis B and C testing in a large urban emergency …

G Nebbia, M Ruf, L Hunter… - Journal of Viral …, 2022 - Wiley Online Library
Innovative testing approaches and care pathways are required to meet global hepatitis B
virus (HBV) and hepatitis C virus (HCV) elimination goals. Routine blood‐borne virus (BBV) …